Lv3
210 积分 2026-08-01 加入
Improved Health-Related quality of Life (HRQoL) with Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib Vs Placebo in Adults with Previously Treated Immune Thrombocytopenia (ITP): Phase 3 Luna 3 Multicenter Study
1个月前
已完结
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
1个月前
已完结
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
1个月前
已完结
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies
1个月前
已完结
Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia
1个月前
已完结
皖公网安备34019202002308
